About

Codiak BioSciences Inc is developing exosome-based therapeutics using its engEx Platform to create engineered exosomes for the treatment of diseases with high unmet medical needs, including oncology and neuromuscular disorders. The company aims to provide targeted delivery of therapeutic agents, improving treatment efficacy and patient outcomes in complex disease areas.

What does do?

Codiak BioSciences Inc is developing exosome-based therapeutics using its engEx Platform to create engineered exosomes for the treatment of diseases with high unmet medical needs, including oncology and neuromuscular disorders. The company aims to provide targeted delivery of therapeutic agents, improving treatment efficacy and patient outcomes in complex disease areas.

Where is located?

is based in Cambridge, United Kingdom.

Location
Cambridge, United Kingdom
0

Find Investable Startups and Competitors

Search thousands of startups using natural language

Start Searching

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

Codiak BioSciences Inc is developing exosome-based therapeutics using its engEx Platform to create engineered exosomes for the treatment of diseases with high unmet medical needs, including oncology and neuromuscular disorders. The company aims to provide targeted delivery of therapeutic agents, improving treatment efficacy and patient outcomes in complex disease areas.

codiakbio.com
Cambridge, United Kingdom

Funding

No funding information available.

Team

No team information available.
Want to add first party data to your startup here or get your entry removed? You can edit it yourself by logging in with your company domain.